...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>BJU international >Roles of the urologist and nurse from the perspective of patients with prostate cancer receiving luteinizing hormone-releasing hormone analogue therapy.
【24h】

Roles of the urologist and nurse from the perspective of patients with prostate cancer receiving luteinizing hormone-releasing hormone analogue therapy.

机译：从接受黄体生成素释放激素类似物治疗的前列腺癌患者的角度来看，泌尿科医师和护士的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

OBJECTIVES: To establish the roles of the urologist, general practitioner (GP) and nurse from the perspective of the patient with prostate cancer receiving hormone therapy, and to assess patient satisfaction, in particular with management and information needs. PATIENTS AND METHODS: Patients with prostate cancer receiving luteinizing hormone-releasing hormone analogue (LHRH-a) therapy were recruited by a representative sample of 58 French urologists (March to April 2007) and invited to complete a 42-item questionnaire. RESULTS: In all, 350 representative patients participated in the study; >90% were totally or quite satisfied with the information given by their urologist at diagnosis and the start of treatment. Their main contact during treatment was with the nurse who gave the injection (84% of patients). The nurse's main role was to provide clarity (60% of patients), guidance (35%) and support to the family (28%). Fewer patients discussed disease stage and progression with their nurse (29%) than witha doctor (urologist, 63%; or GP, 61%). Fewer also discussed treatment (24% vs 32%) but as many patients discussed the impact of their disease and treatment with their nurse as with their doctor (e.g. 33% discussed general health and fatigue with the nurse, vs 26% with the urologist). The need for contact with a health professional was greater during the early stages of treatment. Patients treated for <12 months with 3-monthly injections were less likely to be in favour of spacing injections than patients treated for >or=3 years. CONCLUSION: The patient consults the urologist for reliable information on disease and treatment, and to the GP for further support, if needed, but the nurse has the pivotal role. A 3-monthly injection schedule enables regular face-to-face contact between the nurse and the patient and their family, and contributes towards the patient's coping strategies and quality of life.
机译：目的：从接受激素治疗的前列腺癌患者的角度确定泌尿科医师，全科医生（GP）和护士的作用，并评估患者的满意度，尤其是在管理和信息需求方面。患者和方法：58名法国泌尿科医师的代表性样本（2007年3月至2007年4月）招募了接受黄体激素释放激素类似物（LHRH-a）治疗的前列腺癌患者，并邀请他们填写一份42项问卷。结果：总共有350名代表性患者参加了该研究。 > 90％的人对他们的泌尿科医师在诊断和开始治疗时提供的信息完全或非常满意。他们在治疗期间的主要接触者是打针的护士（84％的患者）。护士的主要作用是向家人提供清晰的声音（占病人的60％），指导（35％）和支持（占28％）。与护士（泌尿科医生，63％;或全科医生，61％）相比，与护士（29％）讨论疾病阶段和进展的患者更少。更少的人也讨论了治疗方法（24％比32％），但是与护士和医生讨论疾病和治疗影响的患者一样多（例如33％的人与护士讨论了整体健康和疲劳，而泌尿科医师则讨论了26％） 。在治疗的早期阶段，与卫生专业人员接触的需求更大。与接受≥3年治疗的患者相比，接受3个月注射治疗<12个月的患者更倾向于间隔注射。结论：如果需要，患者可咨询泌尿科医师以获取有关疾病和治疗的可靠信息，并在需要时向GP寻求进一步支持，但护士起着关键作用。为期3个月的注射时间表可确保护士与患者及其家人之间定期面对面接触，并有助于患者的应对策略和生活质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号